Literature DB >> 30821230

Antimicrobial therapy for asymptomatic bacteriuria or candiduria in advanced cancer patients transitioning to comfort measures.

Rupak Datta1, Tianyun Wang2, Mojun Zhu3, Louise Marie Dembry1, Ling Han4, Heather Allore4, Vincent Quagliarello1, Manisha Juthani-Mehta1.   

Abstract

Among 300 advanced cancer patients with potential urinary tract infection (UTI), 19 had symptomatic UTI. Among remaining patients (n = 281), 21% had asymptomatic bacteriuria or candiduria, and 14% received inappropriate therapy for 279 antimicrobial days. Bacteriuria or candiduria predicted antimicrobial therapy. At 10,000 to <100,000 CFU/mL, the incidence rate ratio [IRR] was 16.9 (95% confidence interval [CI], 6.0-47.2), and at ≥100,000 CFU/mL, the IRR was 27.9 (95% CI, 10.9-71.2).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30821230      PMCID: PMC6482377          DOI: 10.1017/ice.2019.22

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  9 in total

1.  Antimicrobial use at the end of life among hospitalized patients with advanced cancer.

Authors:  Andrew J Thompson; Maria J Silveira; Caroline A Vitale; Preeti N Malani
Journal:  Am J Hosp Palliat Care       Date:  2012-01-04       Impact factor: 2.500

2.  Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults.

Authors:  Lindsay E Nicolle; Suzanne Bradley; Richard Colgan; James C Rice; Anthony Schaeffer; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2005-02-04       Impact factor: 9.079

Review 3.  Community-associated Clostridium difficile infection and antibiotics: a meta-analysis.

Authors:  Abhishek Deshpande; Vinay Pasupuleti; Priyaleela Thota; Chaitanya Pant; David D K Rolston; Thomas J Sferra; Adrian V Hernandez; Curtis J Donskey
Journal:  J Antimicrob Chemother       Date:  2013-04-25       Impact factor: 5.790

4.  Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals?

Authors:  Samuel A Silver; Laura Baillie; Andrew E Simor
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  Symptomatic treatment of infections in patients with advanced cancer receiving hospice care.

Authors:  Raquel E Reinbolt; Allison M Shenk; Patrick H White; Rudolph M Navari
Journal:  J Pain Symptom Manage       Date:  2005-08       Impact factor: 3.612

6.  Effectiveness of an Antimicrobial Stewardship Approach for Urinary Catheter-Associated Asymptomatic Bacteriuria.

Authors:  Barbara W Trautner; Larissa Grigoryan; Nancy J Petersen; Sylvia Hysong; Jose Cadena; Jan E Patterson; Aanand D Naik
Journal:  JAMA Intern Med       Date:  2015-07       Impact factor: 21.873

7.  Clinical uncertainties in the approach to long term care residents with possible urinary tract infection.

Authors:  David A Nace; Paul J Drinka; Christopher J Crnich
Journal:  J Am Med Dir Assoc       Date:  2014-02       Impact factor: 4.669

8.  Antimicrobial use in patients with advanced cancer receiving hospice care.

Authors:  Patrick H White; Heather L Kuhlenschmidt; Benjamin G Vancura; Rudolph M Navari
Journal:  J Pain Symptom Manage       Date:  2003-05       Impact factor: 3.612

Review 9.  Burden and Management of Multidrug-Resistant Organisms in Palliative Care.

Authors:  Rupak Datta; Manisha Juthani-Mehta
Journal:  Palliat Care       Date:  2017-12-19
  9 in total
  1 in total

1.  Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical decisions.

Authors:  Zhengxin He; Xiaosai Huo; Daxin Lei; Huihai Zhao; Keran Jia; Fukun Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-30       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.